Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 16, 2017

View Archived Issues

FDA grants priority review to Verzenio NDA

ZIKV-neutralizing monoclonal antibody cocktail shows promise in nonhuman primates

ASN-100 shows good safety and PK profile for treating Staphylococcus aureus pneumonia

Unacyclated ghrelin analogue from Alize Pharma granted FDA orphan status for Prader-Willi syndrome

FDA accepts ProMetic's BLA for Ryplazim

New PET tracer is specific for bacterial infections

NIH and 11 biopharmaceutical companies partner to launch PACT cancer immunotherapy collaboration

FDA advisory committee votes in favor of Rhopressa

Merz and Teijin sign license and codevelopment agreement for Xeomin in Japan

Impact Biomedicines launched to develop fedratinib for myelofibrosis

Novel NRXN1 gene mutations associated with increased risk of ASD and schizophrenia

SKYZoster approved in South Korea

Janssen, Katholieke Universiteit Leuven describe novel dengue viral replication inhibitors

FDA approves Stelara for adolescents with moderate to severe plaque psoriasis

Toray Industries divulges new dolastatin 10 derivatives

Lysine-specific demethylase 5A inhibitors patented by KIST, Hanyang University

Sun Pharma Advanced Research Co. presents Bruton tyrosine kinase inhibitors

Free fatty acid receptor 1 agonists patented by Merck & Co.

Japan Tobacco enters licensing agreement for Rayaldee in Japan

Genentech, Xenon Pharmaceuticals discover new SCN9A channel blockers

Wellcome announces launch of Global Burden of Disease AMR project

EMA's CHMP supports expansion of marketing authorization for Zytiga

BrainStorm initiates phase III trial of NurOwn for ALS

Health Canada first to approve Shingrix

CLDN5 gene linked to autism pathology

Karyopharm Therapeutics and Ono enter SINE compound agreement

Inotek Pharmaceuticals files statement regarding proposed merger with Rocket Pharmaceuticals

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...